Dr. Prashant K Mukerjee, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 35673 Country Park Dr, Wildomar, CA 92595 Phone: 951-973-8130 Fax: 951-808-0957 |
News Archive
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
Data unveiled today at the American Society of Hypertension Inc.'s 25th Annual Scientific Meeting and Exposition (ASH 2010) suggest children and adolescents of parents with hypertension and larger waist (WC) and hip circumference (HC) should be evaluated for hypertension even if they exhibit normal blood pressure (BP) levels in the doctor's office.
When it comes to revealing a person's age, hands down, the back of the hand is more telling than the face and neck. Fortunately, dermatologists are applying new technologies to add volume to the hand as well as remove dark brown "age spots" to reverse these telltale signs of aging.
Silence Therapeutics plc, a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA-based therapeutics for cancer, today announce that they have entered into an agreement to develop novel microRNA therapeutics for the treatment of cancer.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three and six months ended June 30, 2011.
› Verified 3 days ago